AMY SMITH: Open Payments
NPI 1972547362 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,019 in 38 payments from 16 companies in 2025. Trend: 2023 $1,098 · 2024 $479 · 2025 $1,019
Food & beverage: $1,019
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $297 |
| Phathom Pharmaceuticals, Inc. | 3 | $150 |
| GENZYME CORPORATION | 1 | $132 |
| ABBVIE INC. | 4 | $87 |
| QOL Medical, LLC | 4 | $67 |
| Ardelyx, Inc. | 3 | $52 |
| Novo Nordisk Inc | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Abbott Laboratories | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, VOQUEZNA, Sucraid, IBSRELA, Wegovy, CREON, SKYRIZI.
Industry payments across SC — which companies pay providers there.
